Perma-Fix Environmental Services (PESI) 10-Q 8 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	4-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	PERMA FIX ENVIRONMENTAL SERVICES INC
Document Type	10-Q
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		11,505,141
Amendment Flag	FALSE
Entity Central Index Key	891532
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash	$1,128	$3,680
Restricted cash	152	85
Accounts receivable, net of allowance for doubtful accounts of $2,135 and $2,170, respectively	8,573	8,272
Unbilled receivables - current	7,169	7,177
Inventories	414	498
Prepaid and other assets	3,259	3,010
Deferred tax asset - current	385	385
Current assets related to discontinued operations	18	20
Total current assets	21,098	23,127
Property and equipment:
Buildings and land	19,702	19,863
Equipment	36,064	35,933
Vehicles	403	403
Leasehold improvements	11,613	11,613
Office furniture and equipment	1,819	1,799
Construction-in-progress	306	336
	69,907	69,947
Less accumulated depreciation and amortization	-47,962	-47,123
Net property and equipment	21,945	22,824
Property and equipment related to discontinued operations	681	681
Intangibles and other long term assets:
Permits	16,728	16,709
Other intangible assets - net	2,329	2,435
Unbilled receivables – non-current	451	273
Finite risk sinking fund	21,341	21,334
Other assets	1,215	1,253
Total assets	85,788	88,636
Current liabilities:
Accounts payable	5,800	5,350
Accrued expenses	4,583	4,540
Disposal/transportation accrual	1,941	1,737
Deferred revenue	3,049	4,873
Current liabilities related to discontinued operations	2,127	2,137
Current portion of long-term debt	2,309	2,319
Current portion of long-term debt - related party	1,414	1,414
Total current liabilities	21,223	22,370
Accrued closure costs	5,293	5,508
Other long-term liabilities	818	803
Deferred tax liabilities	5,427	5,391
Long-term liabilities related to discontinued operations	590	590
Long-term debt, less current portion	7,658	6,690
Long-term debt, less current portion - related party	596	949
Total long-term liabilities	20,382	19,931
Total liabilities	41,605	42,301
Commitments and Contingencies (Note 8)	0	0
Series B Preferred Stock of subsidiary, $1.00 par value; 1,467,396 shares authorized, 1,284,730 shares issued and outstanding, liquidation value $1.00 per share plus accrued and unpaid dividends of $818 and $803, respectively	1,285	1,285
Stockholders' Equity:
Common Stock, $.001 par value; 30,000,000 shares authorized; 11,493,817 and 11,476,485 shares issued, respectively; 11,486,175 and 11,468,843 shares outstanding, respectively	11	11
Additional paid-in capital	103,871	103,765
Accumulated deficit	-61,823	-59,758
Accumulated other comprehensive (loss) income	-77	11
Less Common Stock in treasury, at cost; 7,642 shares	-88	-88
Total Perma-Fix Environmental Services, Inc. stockholders' equity	41,894	43,941
Non-controlling interest	1,004	1,109
Total stockholders' equity	42,898	45,050
Total liabilities and stockholders' equity	$85,788	$88,636

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	$2,135	$2,170
Preferred Stock of subsidiary, par value (in Dollars per share)	$1	$1
Preferred Stock of subsidiary, shares authorized	1,467,396	1,467,396
Preferred Stock of subsidiary, shares issued	1,284,730	1,284,730
Preferred Stock of subsidiary, shares outstanding	1,284,730	1,284,730
Preferred Stock of subsidiary, liquidation value per share	1	1
Preferred Stock of subsidiary, accrued and unpaid dividends (in Dollars)	$818	$803
Preferred stock par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares issued	11,493,817	11,476,485
Common stock, shares outstanding	11,486,175	11,468,843
Common Stock in treasury, at cost	7,642	7,642

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Net revenues	$13,600,000	$10,544,000
Cost of goods sold	12,122,000	10,450,000
Gross profit	1,478,000	94,000
Selling, general and administrative expenses	2,871,000	3,212,000
Research and development	404,000	371,000
Loss from operations	-1,797,000	-3,489,000
Interest income	8,000	7,000
Interest expense	-126,000	-153,000
Interest expense-financing fees	-58,000	-45,000
Foreign currency loss	-5,000
Other		7,000
Loss from continuing operations before taxes	-1,978,000	-3,673,000
Income tax expense	36,000	30,000
Loss from continuing operations, net of taxes	-2,014,000	-3,703,000
Loss from discontinued operations, net of taxes	-223,000	-266,000
Net loss	-2,237,000	-3,969,000
Net loss attributable to non-controlling interest	-172,000
Net loss attributable to Perma-Fix Environmental Services, Inc. common stockholders	($2,065,000)	($3,969,000)
Net loss per common share attributable to Pema-Fix Environmental Services, Inc. stockholders - basic and diluted:
Continuing operations (in Dollars per share)	($0.16)	($0.33)
Discontinued operations (in Dollars per share)	($0.02)	($0.02)
Net loss per common share (in Dollars per share)	($0.18)	($0.35)
Number of common shares used in computing net loss per share:
Basic (in Shares)	11,486	11,419
Diluted (in Shares)	11,486	11,419

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Net loss	($2,237)	($3,969)
Other comprehensive loss:
Foreign currency translation loss	-88	-16
Total other comprehensive loss	-88	-16
Comprehensive loss	-2,325	-3,985
Comprehensive loss attributable to non-controlling interest	-172
Comprehensive loss attributable to Perma-Fix Environmental Services, Inc. stockholders	($2,153)	($3,985)

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders’ Equity (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	Total
In Thousands, except Share data
Balance at Dec. 31, 2014	$11	$103,765	($88)	$11	$1,109	($59,758)	$45,050
Balance (in Shares) at Dec. 31, 2014	11,476,485
Net loss					-172	-2,065	-2,237
Foreign currency translation				-88			-88
Perma-Fix Medical S.A. (proceeds from stock subscription receivables)					67		67
Issuance of Common Stock upon exercise of options		3					3
Issuance of Common Stock upon exercise of options (in Shares)	1,257
Issuance of Common Stock for services		70					70
Issuance of Common Stock for services (in Shares)	16,075
Stock-Based Compensation		33					33
Balance at Mar. 31, 2015	$11	$103,871	($88)	($77)	$1,004	($61,823)	$42,898
Balance (in Shares) at Mar. 31, 2015	11,493,817

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Net loss	($2,237)	($3,969)
Less: loss from discontinued operations, net of taxes	-223	-266
Loss from continuing operations, net of taxes	-2,014	-3,703
Adjustments to reconcile loss from continuing operations to cash used in operating activities :
Depreciation and amortization	966	1,211
Amortization of debt discount	22	21
Deferred tax expense	36	30
Benefit for bad debt and other reserves	-34	-9
Issuance of common stock for services	70	64
Stock-based compensation	33	-18
Accounts receivable	-267	534
Unbilled receivables	-170	-755
Prepaid expenses, inventories and other assets	-4	181
Accounts payable, accrued expenses and unearned revenue	-1,334	103
Cash used in continuing operations	-2,696	-2,341
Cash (used in) provided by discontinued operations	-232	861
Cash used in operating activities	-2,928	-1,480
Cash flows from investing activities:
Purchases of property and equipment, net	-121	-213
Payment to finite risk sinking fund	-7	-7
Cash used in investing activities	-128	-220
Cash flows from financing activities:
Repayments of revolving credit borrowings	-14,263	-14,253
Borrowing on revolving credit	15,808	16,286
Proceeds from issuance of common stock	3
Principal repayments of long term debt	-587	-618
Principal repayments of long term debt - related party	-375
Cash provided by financing activities of continuing operations	586	1,415
Principal repayments of long term debt for discontinued operations		-9
Cash provided by financing activities	586	1,406
Effect of exchange rate changes in cash	-82
Decrease in cash	-2,552	-294
Cash at beginning of period	3,680	333
Cash at end of period	1,128	39
Interest paid	132	144
Income taxes paid	$10	$18

Note_1_Basis_of_Presentation

Note 1 - Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1	Basis of Presentation
	The consolidated condensed financial statements included herein have been prepared by the Company (which may be referred to as we, us or our), without an audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“the Commission”). Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes the disclosures which are made are adequate to make the information presented not misleading. Further, the consolidated condensed financial statements reflect, in the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations as of and for the periods indicated. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of results to be expected for the fiscal year ending December 31, 2015.
	The Company suggests that these consolidated condensed financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014.
	Reclassification
	Certain prior year amounts have been reclassified to conform with the current year presentation.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2	Summary of Significant Accounting Policies
	Our accounting policies are as set forth in the notes to the December 31, 2014 consolidated financial statements referred to above.
	Recently Issued Accounting Standards – Not Yet Adopted
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 provides a single, comprehensive revenue recognition model for all contracts with customers. The revenue guidance contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. On April 1, 2015, the FASB proposed deferring the effective date of ASU 2014-09 by one year to December 15, 2017 for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, “Compensation Stock – Compensation (Topic 718).” ASU 2014-12 applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. It requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition and follows existing accounting guidance for the treatment of performance conditions. The standard is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In November 2014, the FASB issued ASU, 2014-16, “Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity.” ASU 2014-06 clarifies how current guidance should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of a host contract. The ASU is effective for fiscal years and interim periods beginning after December 15, 2015. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In January 2015, the FASB issued ASU 2015-01, “Income Statement-Extraordinary and Unusual Items.” ASU 2015-01 eliminates from GAAP the concept of extraordinary items. ASU 2015-01 is effective for annual reporting periods and interim periods, within those annual periods beginning after December 15, 2015.  The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In February 2015, the FASB issued Accounting Standards Update No. 2015-02, "Consolidation (Topic 810): Amendments to the Consolidation Analysis.” ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In April 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." ASU 2015-03 amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.

Note_3_Intangible_Assets

Note 3 - Intangible Assets	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	3	Intangible Assets
	The following table summarizes information relating to the Company’s definite-lived intangible assets:
					31-Mar-15							31-Dec-14
			Useful		Gross					Net		Gross					Net
			Lives		Carrying		Accumulated			Carrying		Carrying		Accumulated			Carrying
	(amount in thousands)		(Years)		Amount		Amortization			Amount		Amount		Amortization			Amount
	Intangibles
	Patent			18-Aug	$	512	$	(177	)	$	335	$	512	$	(168	)	$	344
	Software			3		382		(339	)		43		375		(319	)		56
	Customer relationships			12		3,370		(1,419	)		1,951		3,370		(1,335	)		2,035
	Permit			10		545		(332	)		213		545		(318	)		227
	Total				$	4,809	$	(2,267	)	$	2,542	$	4,802	$	(2,140	)	$	2,662
	The intangible assets noted above are amortized on a straight-line basis over their useful lives with the exception of customer relationships which were being amortized using an accelerated method. The Company has only one definite-lived permit that is subject to amortization.
	The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets:
			Amount
	Year		(In thousands)
	2015 (remaining)		$	376
	2016			425
	2017			391
	2018			361
	2019			280
			$	1,833
	Amortization expenses relating to the definite-lived intangible assets as discussed above were $127,000 and $176,000 for the three months ended March 31, 2015 and 2014, respectively.

Note_4_Capital_Stock_Stock_Pla

Note 4 - Capital Stock, Stock Plans and Stock Based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	4	Capital Stock, Stock Plans and Stock Based Compensation
	The Company has certain stock option plans under which it awards incentive and non-qualified stock options to employees, officers, and outside directors. No stock options were granted during the first quarter of 2015 or 2014.
	As of March 31, 2015, the Company had an aggregate of 55,000 employee stock options outstanding (from the 2010 Stock Option Plans), of which none are vested. The weighted average exercise price of the 55,000 outstanding employee stock options is $5.00 with a remaining weighted contractual life of 5.3 years. Additionally, we had an aggregate of 167,766 outstanding director stock options (from the 2003 Outside Directors Stock Plans), of which all are vested. The weighted average exercise price of the 167,766 outstanding and fully vested director stock options is $8.84 with a remaining weighted contractual life of 4.9 years.
	The summary of the Company’s total Stock Option Plans as of March 31, 2015, as compared to March 31, 2014, and changes during the periods then ended, are presented below. The Company’s Plans consist of the 2010 and 2004 Stock Option Plans, and the 2003 Outside Directors Stock Plans (“2003 Plan”):
									Weighted Average
						Weighted			Remaining		Aggregate
						Average			Contractual		Intrinsic
			Shares			Exercise Price			Term (years)		Value
	Options outstanding January 1, 2015			239,023		$	7.81
	Granted			—			—
	Exercised			(1,257	)		2.79				$	2,043
	Forfeited/expired			(15,000	)		7.1
	Options outstanding end of period (1)			222,766			7.89			5	$	22,616
	Options exercisable at March 31, 2015(1)			167,766		$	8.84			4.9	$	22,616
	Options vested and expected to be vested at March 31, 2015			213,966		$	8.01			5	$	22,616
									Weighted Average
						Weighted			Remaining		Aggregate
						Average			Contractual		Intrinsic
			Shares			Exercise Price			Term (years)		Value
	Options outstanding January 1, 2014			362,800		$	9.53
	Granted			—			—
	Exercised			—			—				$	—
	Forfeited/expired			(22,000	)		8.17
	Options outstanding end of period (1)			340,800			9.62			2.7	$	47,790
	Options exercisable at March 31, 2014(1)			334,800		$	9.73			2.6	$	37,710
	Options vested and expected to be vested at March 31, 2014			340,800		$	9.62			2.7	$	47,790
	(1) Options with exercise prices ranging from $2.79 to $14.75
	The Company estimates the fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate the fair value of stock options granted include the exercise price of the award, the expected term, the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest rate over the option’s expected term, and the expected annual dividend yield.
	The following table summarizes stock-based compensation recognized for the three months ended March 31, 2015 and 2014 for our employee and director stock options.
			Three Months Ended
	Stock Options		March 31,
			2015			2014
	Employee Stock Options		$	13,000		$	(39,000	)
	Director Stock Options			20,000			21,000
	Total		$	33,000		$	(18,000	)
	The Company recognized stock-based compensation expense using a straight-line amortization method over the requisite service period, which is the vesting period of the stock option grant. Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has generally estimated forfeiture rates based on historical trends of actual forfeitures. When actual forfeitures vary from our estimates, the Company recognizes the difference in compensation expense in the period the actual forfeitures occur or when options vest. The total stock-based compensation expense for the three months ended March 31, 2014 included a reduction in expense of approximately $54,000 resulting from the forfeiture of options by Mr. Jim Blankenhorn, our Chief Operating Officer (“COO”), who voluntarily resigned from the Company effective March 28, 2014. The COO was granted an option from the Company’s 2010 Stock Option Plan on July 25, 2011, to purchase up to 60,000 shares of the Company’s Common Stock at $7.85 per share. The options had a six year contractual term with one-third yearly vesting over a three year period.
	As of March 31, 2015, the Company has approximately $112,000 of total unrecognized compensation cost related to unvested options, of which $40,000 is expected to be recognized in remaining 2015, $53,000 in 2016, with the remaining $19,000 in 2017.
	During the three months ended March 31, 2015, the Company issued a total of 16,075 shares of our Common Stock under our 2003 Plan to our outside directors as compensation for serving on our Board of Directors. Also, an outside director exercised 1,257 options from the 2003 Plan for the purchase of 1,257 shares of the Company’s Common Stock at $2.79 per share.

Note_5_Loss_Per_Share

Note 5 - Loss Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	5	Loss Per Share
	Basic loss per share is calculated based on the weighted-average number of outstanding common shares during the applicable period. Diluted loss per share is based on the weighted-average number of outstanding common shares plus the weighted-average number of potential outstanding common shares. Loss per share is computed separately for each period presented.
	The diluted loss per share calculations exclude options to purchase approximately 185,800 and 316,800 shares of common stock for the three months ended March 31, 2015 and 2014, respectively, because their effect would have been antidilutive as a result of the net losses recorded in these periods for continuing operations.

Note_6_Long_Term_Debt

Note 6 - Long Term Debt	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	6	Long Term Debt
	Long-term debt consists of the following at March 31, 2015 and December 31, 2014:
	(Amounts in Thousands)		March 31,		December 31,
			2015		2014
	Revolving Credit facility dated October 31, 2011, borrowings based upon eligible accounts receivables, subject to monthly borrowing base calculation, variable interest paid monthly at option of prime rate (3.25% at March 31, 2015) plus 2.0% or London Interbank Offer Rate ("LIBOR") plus 3.0%, balance due October 31, 2016. Effective interest rate for the first quarter of 2015 was 3.8%. (1)		$	1,545	$	—
	Term Loan dated October 31, 2011, payable in equal monthly installments of principal of $190, balance due on October 31, 2016, variable interest paid monthly at option of prime rate plus 2.5% or LIBOR plus 3.5%. Effective interest rate for the first quarter of 2015 was 3.7%. (1)			8,381		8,952
	Promissory Note dated February 12, 2013, payable in monthly installments of $10, which includes interest and principal, starting February 28, 2013, interest accrues at annual rate of 6.0%, paid in full on January 30, 2015. (2)			—		10
	Promissory Note dated August 2, 2013, payable in twelve monthly installments of interest only, starting September 1, 2013 and twenty-four monthly installments of $125 in principal plus accrued interest. Interest accrues at annual rate of 2.99%. (2) (3)			2,010		2,363
	Capital lease (interest at rate of 6.0%)			41		47
				11,977		11,372
	Less current portion of long-term debt			3,723		3,733
			$	8,254	$	7,639
	(1) Our Revolving Credit facility is collateralized by our accounts receivable and our Term Loan is collateralized by our property, plant, and equipment.
	(2) Uncollateralized note.
	(3) Net of debt discount of ($115,000) and ($137,000) for March 31, 2015 and December 31, 2014, respectively. See “Promissory Notes and Installment Agreements” below for additional information.
	Revolving Credit and Term Loan Agreement
	The Company entered into an Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated October 31, 2011, (“Loan Agreement”), with PNC Bank, National Association (“PNC”), acting as agent and lender. The Loan Agreement, as amended (“Amended Loan Agreement”), provides us with the following Credit Facility: (a) up to $12,000,000 revolving credit facility (“Revolving Credit”), subject to the amount of borrowings based on a percentage of eligible receivables (as defined) and (b) a term loan (“Term Loan”) of $16,000,000, which requires monthly installments of approximately $190,000 (based on a seven-year amortization).
	The Amended Loan Agreement terminates as of October 31, 2016, unless sooner terminated. We may terminate the Amended Loan Agreement upon 90 days’ prior written notice and upon payment in full of our obligations under the Amended Loan Agreement.
	Our Credit Facility with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our Credit Facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. The Company met its quarterly fixed charge coverage ratio and minimum tangible adjusted net worth requirements in the first quarter of 2015.
	As of March 31, 2015, the availability under our revolving credit was $3,023,000, based on our eligible receivables and includes an indefinite reduction of borrowing availability of $1,500,000. On July 28, 2014, the Company entered into an amendment to the Amended Loan Agreement which among other things, authorized the Company to use the $3,850,000 insurance settlement proceeds received on June 30, 2014 by our Perma-Fix of South Georgia, Inc. (“PFSG”) subsidiary (which suffered a fire on August 14, 2013 and is included within our discontinued operations) for working capital purposes but placed an indefinite reduction on our borrowing availability by the $1,500,000 as discussed above.
	Promissory Notes and Installment Agreements
	On February 12, 2013, the Company entered into an unsecured promissory note (“the new note”) with Timios National Corporation (“TNC”) in the principal amount of approximately $230,000 as a result of a settlement with TNC in connection with certain claims that the Company asserted against TNC for breach of certain representations and covenant subsequent to our acquisition of Safety & Ecology Corporation (“SEC”) from TNC on October 31, 2011. The new note was entered into as a result of the settlement in which a previously issued promissory note (with principal balance of $1,460,000 at February 12, 2013) that the Company entered into with TNC as partial consideration of the purchase price of SEC was cancelled and terminated and replaced with the new note. Final payment of approximately $10,000 on this note was made in January 2015.
	On August 2, 2013, the Company completed a lending transaction with Messrs. Robert Ferguson (who serves as an advisor to the Company’s Board of Directors) and William Lampson (“collectively, the “Lenders”), whereby the Company borrowed from the Lenders the sum of $3,000,000 pursuant to the terms of a Loan and Security Purchase Agreement and promissory note (the “Loan”) (See payment terms of this promissory note in the table above). In connection with this Loan, the Lenders entered into a Subordination Agreement dated August 2, 2013, with the Company’s Credit Facility lender, whereby the Lenders agreed to subordinate payment under the Loan, and agreed that the Loan will be junior in right of payment to the Credit Facility in the event of default or bankruptcy or other insolvency proceeding by the Company. As consideration for the Company receiving the Loan, the Company issued a Warrant to each Lender to purchase up to 35,000 shares of the Company’s Common Stock at an exercise price based on the closing price of the Company’s Common Stock at the closing of the transaction which was determined to be $2.23. The Warrants are exercisable six months from August 2, 2013 and expire on August 2, 2016. The fair value of the Warrants was estimated to be approximately $59,000 using the Black-Scholes option pricing model. As further consideration for the Loan, the Company also issued an aggregate 90,000 shares of the Company’s Common Stock, with each Lender receiving 45,000 shares. The Company determined the fair value of the 90,000 shares of Common Stock to be approximately $200,000 which was based on the closing price of the stock of $2.23 per share on August 2, 2013. The fair value of the Warrants and Common Stock and the related closing fees incurred from the transaction were recorded as a debt discount, which is being amortized using the effective interest method over the term of the loan as interest expense – financing fees.
	In the event of default of the promissory note by the Company, the Lenders have the option to receive a cash payment equal to the amount of the unpaid principal balance plus all accrued and unpaid interest (“Payoff Amount”), or the number of whole shares of the Company’s Common Stock equal to the Payoff Amount divided by the closing bid price of the Company’s Common Stock on the date immediately prior to the date of default of the promissory note, as reported by the primary national securities exchange on which the Company’s Common Stock is traded. The maximum number of payoff shares is restricted to less than 20% of the outstanding equity.

Note_7_PermaFix_Medical_SA

Note 7 - Perma-Fix Medical S.A.	3 Months Ended
	Mar. 31, 2015
Perma Fix Medical SA [Abstract]
Perma Fix Medical SA [Text Block]	7	Perma-Fix Medical S.A.
	On April 4, 2014, the Company completed the acquisition of a controlling interest in a Polish Company, a publicly traded shell company on the NewConnect (alternative share market run by the Warsaw Stock Exchange) in Poland and sold to the Polish shell all of the shares of Perma-Fix Medical Corporation, a Delaware corporation (“PF Medical”) organized by the Company (incorporated in January 2014). PF Medical’s only asset was and is a worldwide license granted by the Company to use, develop and market the new process and technology developed by the Company in the production of Technetium-99 or “Tc-99m” for medical diagnostic applications. Since the acquired shell company (now named as Perma-Fix Medical S.A.) does not meet the definition of a business under ASC 805, “Business Combinations”, the transaction was accounted for as a capital transaction. The primary purpose of PF Medical S.A. (which we own 64%) is to provide a financing vehicle for the development and marketing of its medical isotope (“Tc-99m”) technology used in medical diagnostic testing for potential use throughout the world.
	During August, 2014, PF Medical S.A. executed stock subscription agreements totaling approximately $2,357,000 for 250,000 shares of its Series E Common Stock to non-U.S. persons in an offshore private placement under Regulation S promulgated under the Securities Act of 1933, as amended (“Securities Act”). In connection with this transaction, as of March 31, 2015, PF Medical S.A. has received approximately $1,545,000 in payment (of which approximately $67,000 was received in the first quarter of 2015) for the 250,000 shares (before deduction for commissions and legal expenses relating to this offering of approximately $242,000). The $67,000 is being held in an escrow account as the proceeds will be used to pay for potential future expenses related to the medical isotope project. The Company has recorded the amount held in escrow as restricted cash on the accompanying Consolidated Balance Sheet. PF Medical S.A. expects to receive the remaining proceeds for the stock subscription receivables by December 2015. The remaining stock subscription receivables are offset against non-controlling interest. If PF Medical S.A. does not receive approximately $592,000 of the remaining stock subscription receivables, which represents approximately 68,181 shares, PF Medical S.A. has the option to have the purchaser of such shares transfer all of its rights, title and interest in such shares to PF Medical S.A. or for PF Medical S.A. be paid for the 68,161 shares with shares in another publicly traded company.

Note_8_Commitments_and_Conting

Note 8 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	8	Commitments and Contingencies
	Hazardous Waste
	In connection with our waste management services, we handle both hazardous and non-hazardous waste, which we transport to our own, or other, facilities for destruction or disposal. As a result of disposing of hazardous substances, in the event any cleanup is required, we could be a potentially responsible party for the costs of the cleanup notwithstanding any absence of fault on our part.
	Legal Matters
	In the normal course of conducting our business, we are involved in various litigation. We are not a party to any litigation or governmental proceeding which our management believes could result in any judgments or fines against us that would have a material adverse effect on our financial position, liquidity or results of future operations.
	Insurance
	The Company has a 25-year finite risk insurance policy entered into in June 2003 with American International Group, Inc. (“AIG”), which provides financial assurance to the applicable states for our permitted facilities in the event of unforeseen closure. The policy, as amended, provides for a maximum allowable coverage of $39,000,000 and has available capacity to allow for annual inflation and other performance and surety bond requirements. All of the required payments for this finite risk insurance policy, as amended, were made by 2012. As of March 31, 2015, our financial assurance coverage amount under this policy totaled approximately $38,454,000. The Company has recorded $15,435,000 in our sinking fund related to the policy noted above in other long term assets on the accompanying consolidated balance sheets, which includes interest earned of $963,000 on the sinking fund as of March 31, 2015. Interest income for three months ended March 31, 2015, was approximately $6,000. If the Company so elects, AIG is obligated to pay us an amount equal to 100% of the sinking fund account balance in return for complete release of liability from both us and any applicable regulatory agency using this policy as an instrument to comply with financial assurance requirements.
	In August 2007, the Company entered into a second finite risk insurance policy for our Perma-Fix Northwest Richland, Inc. (“PFNWR”) facility with AIG. The policy provided an initial $7,800,000 of financial assurance coverage with an annual growth rate of 1.5%, which at the end of the four year term policy, provides maximum coverage of $8,200,000. The Company has made all of the required payments on this policy. As of March 31, 2015, the Company has recorded $5,906,000 in our sinking fund related to this policy in other long term assets on the accompanying consolidated balance sheets, which includes interest earned of $206,000 on the sinking fund as of March 31, 2015. Interest income for the three months ended March 31, 2015, was approximately $1,000. This policy is renewed annually at the end of the four year term with a nominal fee for the variance between the coverage requirement and the sinking fund balance. The Company has renewed this policy annually from 2011 to 2014 (with fees ranging from $41,000 to $46,000 annually). All other terms of the policy remain substantially unchanged.
	Letter of Credits and Bonding Requirements
	From time to time, we are required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. As of March 31, 2015, the total amount of these bonds and letters of credit outstanding was approximately $1,773,000, of which the majority of the amount relates to various bonding requirements.

Note_9_Discontinued_Operations

Note 9 - Discontinued Operations	3 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	9	Discontinued Operations
	The Company’s discontinued operations consist of all our subsidiaries included in our Industrial Segment: (1) subsidiaries divested in 2011 and prior, (2) two previously closed locations, and (3) our PFSG facility. On August 14, 2013, our PFSG facility incurred fire damage which left it non-operational. The Company carries general liability, pollution, property and business interruption, and workers compensation insurance with a maximum deductible of approximately $300,000. During the second half of 2014, the Company entered into a settlement agreement and release with one of its insurance carriers. In 2014, the Company elected not to rebuild the PFSG facility and is continuing to market PFSG for sale.
	The Company’s discontinued operations had losses of $223,000 and $266,000 for the three months ended March 31, 2015 and the corresponding period of 2014 (net of taxes of $0 for each period). The losses were primarily due to costs incurred in the administration and continued monitoring of our discontinued operations, primarily for the PFSG site. The Company’s discontinued operations had no revenues for each of the periods noted above.
	The following table presents the major classes of assets and liabilities of discontinued operations that are classified as held for sale as of March 31, 2015 and December 31, 2014. The held for sale assets and liabilities may differ at the closing of a sale transaction from the reported balances as of March 31, 2015:
			March 31,		December 31,
	(Amounts in Thousands)		2015		2014
	Current assets
	Other assets			5		6
	Total current assets			5		6
	Long-term assets
	Property, plant and equipment, net (1)			644		644
	Total long-term assets			644		644
	Total assets held for sale		$	649	$	650
	Current liabilities
	Accounts payable		$	883	$	932
	Accrued expenses and other liabilities			202		193
	Total current liabilities			1,085		1,125
	Total liabilities held for sale		$	1,085	$	1,125
	(1)net of accumulated depreciation of $0 for each period presented.
	The following table presents the major classes of assets and liabilities of discontinued operations that are not held for sale as of March 31, 2015 and December 31, 2014:
			March 31,		December 31,
	(Amounts in Thousands)		2015		2014
	Current assets
	Other assets		$	13		14
	Total current assets			13		14
	Long-term assets
	Property, plant and equipment, net (1)			37		37
	Total long-term assets			37		37
	Total assets not held for sale		$	50	$	51
	Current liabilities
	Accounts payable		$	33	$	15
	Accrued expenses and other liabilities			281		269
	Environmental liabilities			728		728
	Total current liabilities			1,042		1,012
	Long-term liabilities
	Closure liabilities			302		302
	Environmental liabilities			288		288
	Total long-term liabilities			590		590
	Total liabilities not held for sale		$	1,632	$	1,602
	(1)net of accumulated depreciation of $10,000 for each period presented.

Note_10_Operating_Segments

Note 10 - Operating Segments	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	10	Operating Segments
	In accordance with ASC 280, “Segment Reporting”, we define an operating segment as a business activity: (a) from which we may earn revenue and incur expenses; (2) whose operating results are regularly reviewed by the Chief Operating Officer (our Chief Operating Decision Maker) to make decisions about resources to be allocated to the segment and assess its performance; and (3) for which discrete financial information is available.
	We currently have two reporting segments, Treatment and Services Segments, which are based on a service offering approach. This, however, excludes corporate headquarters, which do not generate revenue, our discontinued operations (see Note 9 – “Discontinued Operations”), and PF Medical S.A, a developmental entity whose primary purpose at this time is the R&D and marketing of medical isotope technology used in the medical diagnostic testing and is not generating any revenues (see Note 7 – “Perma-Fix Medical S.A.” for further information of this entity).
	Our reporting segments are defined as below:
	TREATMENT SEGMENT reporting includes:
		-	nuclear, low-level radioactive, mixed, hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
		-	R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.
	SERVICES SEGMENT, which includes:
		-	On-site waste management services to commercial and government customers;
		-	Technical services, which include:
		o	professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
		o	integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance;
		o	global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning field, technical, and management personnel and services to commercial and government customers;
		-	Nuclear services, which include:
		o	technology-based services including engineering, decontamination and decommissioning (“D&D”), specialty services and construction, logistics, transportation, processing and disposal;
		o	remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; site construction; logistics; transportation; and emergency response; and
		-	A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) of health physics, IH and customized nuclear, environmental, and occupational safety and health (“NEOSH”) instrumentation.
	The table below presents certain financial information of our operating segments as of and for the three months ended March 31, 2015 and 2014 (in thousands).
	Segment Reporting as of and for the Quarter Ended March 31, 2015
			Treatment			Services			Segments			Corporate			-1	Consolidated
									Total			And Other				Total
	Revenue from external customers		$	9,749		$	3,851		$	13,600		$	—			$	13,600
	Intercompany revenues			2			8			10			—				—
	Gross profit			1,235			243			1,478			—				1,478
	Interest income			—			—			—			8				8
	Interest expense			(22	)		—			(22	)		(104	)			(126	)
	Interest expense-financing fees			—			—			—			(58	)			(58	)
	Depreciation and amortization			764			190			954			12				966
	Segment profit (loss), net of taxes			185			(303	)		(118	)		(1,896	)			(2,014	)
	Expenditures for segment assets			104			16			120			1				121
	Segment Reporting as of and for the Quarter Ended March 31, 2014
			Treatment			Services			Segments			Corporate			-1	Consolidated
									Total			And Other				Total
	Revenue from external customers		$	7,673		$	2,871		$	10,544		$	—			$	10,544
	Intercompany revenues			1			11			12			—				—
	Gross profit (negative gross profit)			111			(17	)		94			—				94
	Interest income			—			—			—			7				7
	Interest expense			(10	)		—			(10	)		(143	)			(153	)
	Interest expense-financing fees			—			—			—			(45	)			(45	)
	Depreciation and amortization			949			249			1,198			13				1,211
	Segment loss, net of taxes			(1,174	)		(1,048	)		(2,222	)		(1,481	)			(3,703	)
	Expenditures for segment assets			211			2			213			—				213
	(1) Amounts reflect the activity for corporate headquarters (in both periods presented) and PF Medical S.A. (for quarter ended March 31, 2015 only), not included in the segment information.

Note_11_Income_Taxes

Note 11 - Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	11	Income Taxes
	The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes.
	Income tax expenses were $36,000 and $30,000 for continuing operations for the three months ended March 31, 2015 and the corresponding period of 2014, respectively. The Company’s effective tax rate was approximately (2.0%) for the three months ended March 31, 2015 as compared to a tax rate of approximately (.08%) for the corresponding period of 2014. The Company has provided a full valuation allowance on its net deferred tax assets.

Note_12_Subsequent_Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	12	Subsequent Events
	Management Incentive Plans (MIPs)
	On April 17, 2015, the Company’s Compensation and Stock Option Committee (“Compensation Committee”) approved individual MIPs for Dr. Louis F. Centofanti, our Chief Executive Officer (“CEO”), John Lash, our Chief Operating Officer (“COO”), and Ben Naccarato, our Chief Financial Officer (“CFO”). The MIPs are effective as of January 1, 2015. Each MIP provides guidelines for the calculation of annual cash incentive based compensation, subject to Compensation Committee oversight and modification. Each MIP awards cash compensation based on achievement of performance thresholds, with the amount of such compensation established as a percentage of base salary. The potential target performance compensation ranges from 5% to 100% or $13,556 to $271,115 of the 2015 base salary for the CEO, 5% to 100% or $10,750 to $215,000 of the 2015 base salary for the COO, and 5% to 100% or $10,712 to $214,240 of the 2015 base salary for the CFO.
	The performance compensation payable under each MIP is based upon achievement of certain levels of corporate revenue, EBITDA, health and safety, and environmental compliance (permit and license violations) targets and objectives during fiscal year 2015 from our continuing operations, with such targets and objectives approved by the Company’s Board of Directors. EBITDA, a non-GAAP financial measurement, is defined as earnings before interest, taxes, depreciation and amortization. The Compensation Committee believe performance compensation payable under each of the MIPs should be based on achievement of EBITDA target as this target provides better indicator of operating performance as it excludes certain non-cash items. EBITDA has certain limitations as it does not reflect all items of income or cash flows that affect the Company’s financial performance under GAAP.
	Performance compensation is paid on or about 90 days after year-end, or sooner, based on finalization of our audited financial statements for 2015. If the MIP participant’s employment with the Company is voluntarily or involuntarily terminated prior to a regularly scheduled MIP compensation payment date, no MIP payment will be payable for and after such period.  The Compensation Committee retains the right to modify, change or terminate each MIP and may adjust the various target amounts described below, at any time and for any reason. The total paid to the CEO, COO, and CFO will not exceed 50% of the Company’s pre-tax net income prior to the calculation of performance compensation.
	Perma-Fix Medical S.A.
	On April 30, 2015, Perma-Fix Medical S.A. officially accepted a grant funding awarded by the National Centre for Research and Development (“NCRD”) in Poland to further develop and commercialize a novel prototype generator for the production of Tc-99m for use in cancer and cardiac imaging (“Generator Project”). The Generator Project is under the leadership and supervision of Perma-Fix Medical S.A. and consists of four additional entities from Poland, including: the National Centre for Nuclear Research - Radioisotope Centre POLATOM in Otwock; the Institute for Biopolymers and Chemical Fibers - Department of Biopolymers in Lódz; Warsaw Medical University - Department of Nuclear Administration; and the Institute of Industrial Organic Chemistry Branch in Pszczyna (together known as the “Generator Project team”). The total Generator Project budget is approximately $3,700,000, of which NCRD’s subsidy grant for the Generator Project is approximately $2,800,000 and will be funded by NCRD over a four year period. If needed, Perma-Fix Medical expects to fund any capital requirements in excess of the subsidy grant for the Generator Project allocated by NCRD through the sale of equity. Of the $2,800,000 subsidy grant allocation, Perma-Fix Medical S.A. will directly receive approximately $800,000 and the remaining amount will be allocated to other members of the Generator Project team to be used solely to support technology development and testing of the Generator Project. An initial subsidy grant for the Generator Project in the amount of approximately $240,000 is expected to be funded by NCRD during the second quarter of 2015, with the remaining subsidy grant to be funded based on milestone completion of the Generator Project.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
New Accounting Pronouncements Not Yet Adopted [Policy Text Block]	Recently Issued Accounting Standards – Not Yet Adopted
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 provides a single, comprehensive revenue recognition model for all contracts with customers. The revenue guidance contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. On April 1, 2015, the FASB proposed deferring the effective date of ASU 2014-09 by one year to December 15, 2017 for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, “Compensation Stock – Compensation (Topic 718).” ASU 2014-12 applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. It requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition and follows existing accounting guidance for the treatment of performance conditions. The standard is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In November 2014, the FASB issued ASU, 2014-16, “Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity.” ASU 2014-06 clarifies how current guidance should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. Specifically, the amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of a host contract. The ASU is effective for fiscal years and interim periods beginning after December 15, 2015. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In January 2015, the FASB issued ASU 2015-01, “Income Statement-Extraordinary and Unusual Items.” ASU 2015-01 eliminates from GAAP the concept of extraordinary items. ASU 2015-01 is effective for annual reporting periods and interim periods, within those annual periods beginning after December 15, 2015.  The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In February 2015, the FASB issued Accounting Standards Update No. 2015-02, "Consolidation (Topic 810): Amendments to the Consolidation Analysis.” ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In April 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." ASU 2015-03 amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.

Note_3_Intangible_Assets_Table

Note 3 - Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]				31-Mar-15							31-Dec-14
		Useful		Gross					Net		Gross					Net
		Lives		Carrying		Accumulated			Carrying		Carrying		Accumulated			Carrying
	(amount in thousands)	(Years)		Amount		Amortization			Amount		Amount		Amortization			Amount
	Intangibles
	Patent		18-Aug	$	512	$	(177	)	$	335	$	512	$	(168	)	$	344
	Software		3		382		(339	)		43		375		(319	)		56
	Customer relationships		12		3,370		(1,419	)		1,951		3,370		(1,335	)		2,035
	Permit		10		545		(332	)		213		545		(318	)		227
	Total			$	4,809	$	(2,267	)	$	2,542	$	4,802	$	(2,140	)	$	2,662
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]		Amount
	Year	(In thousands)
	2015 (remaining)	$	376
	2016		425
	2017		391
	2018		361
	2019		280
		$	1,833

Note_4_Capital_Stock_Stock_Pla1

Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]								Weighted Average
					Weighted			Remaining		Aggregate
					Average			Contractual		Intrinsic
		Shares			Exercise Price			Term (years)		Value
	Options outstanding January 1, 2015		239,023		$	7.81
	Granted		—			—
	Exercised		(1,257	)		2.79				$	2,043
	Forfeited/expired		(15,000	)		7.1
	Options outstanding end of period (1)		222,766			7.89			5	$	22,616
	Options exercisable at March 31, 2015(1)		167,766		$	8.84			4.9	$	22,616
	Options vested and expected to be vested at March 31, 2015		213,966		$	8.01			5	$	22,616
								Weighted Average
					Weighted			Remaining		Aggregate
					Average			Contractual		Intrinsic
		Shares			Exercise Price			Term (years)		Value
	Options outstanding January 1, 2014		362,800		$	9.53
	Granted		—			—
	Exercised		—			—				$	—
	Forfeited/expired		(22,000	)		8.17
	Options outstanding end of period (1)		340,800			9.62			2.7	$	47,790
	Options exercisable at March 31, 2014(1)		334,800		$	9.73			2.6	$	37,710
	Options vested and expected to be vested at March 31, 2014		340,800		$	9.62			2.7	$	47,790
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]		Three Months Ended
	Stock Options	March 31,
		2015			2014
	Employee Stock Options	$	13,000		$	(39,000	)
	Director Stock Options		20,000			21,000
	Total	$	33,000		$	(18,000	)

Note_6_Long_Term_Debt_Tables

Note 6 - Long Term Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	(Amounts in Thousands)	March 31,		December 31,
		2015		2014
	Revolving Credit facility dated October 31, 2011, borrowings based upon eligible accounts receivables, subject to monthly borrowing base calculation, variable interest paid monthly at option of prime rate (3.25% at March 31, 2015) plus 2.0% or London Interbank Offer Rate ("LIBOR") plus 3.0%, balance due October 31, 2016. Effective interest rate for the first quarter of 2015 was 3.8%. (1)	$	1,545	$	—
	Term Loan dated October 31, 2011, payable in equal monthly installments of principal of $190, balance due on October 31, 2016, variable interest paid monthly at option of prime rate plus 2.5% or LIBOR plus 3.5%. Effective interest rate for the first quarter of 2015 was 3.7%. (1)		8,381		8,952
	Promissory Note dated February 12, 2013, payable in monthly installments of $10, which includes interest and principal, starting February 28, 2013, interest accrues at annual rate of 6.0%, paid in full on January 30, 2015. (2)		—		10
	Promissory Note dated August 2, 2013, payable in twelve monthly installments of interest only, starting September 1, 2013 and twenty-four monthly installments of $125 in principal plus accrued interest. Interest accrues at annual rate of 2.99%. (2) (3)		2,010		2,363
	Capital lease (interest at rate of 6.0%)		41		47
			11,977		11,372
	Less current portion of long-term debt		3,723		3,733
		$	8,254	$	7,639

Note_9_Discontinued_Operations1

Note 9 - Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]		March 31,		December 31,
	(Amounts in Thousands)	2015		2014
	Current assets
	Other assets		5		6
	Total current assets		5		6
	Long-term assets
	Property, plant and equipment, net (1)		644		644
	Total long-term assets		644		644
	Total assets held for sale	$	649	$	650
	Current liabilities
	Accounts payable	$	883	$	932
	Accrued expenses and other liabilities		202		193
	Total current liabilities		1,085		1,125
	Total liabilities held for sale	$	1,085	$	1,125
		March 31,		December 31,
	(Amounts in Thousands)	2015		2014
	Current assets
	Other assets	$	13		14
	Total current assets		13		14
	Long-term assets
	Property, plant and equipment, net (1)		37		37
	Total long-term assets		37		37
	Total assets not held for sale	$	50	$	51
	Current liabilities
	Accounts payable	$	33	$	15
	Accrued expenses and other liabilities		281		269
	Environmental liabilities		728		728
	Total current liabilities		1,042		1,012
	Long-term liabilities
	Closure liabilities		302		302
	Environmental liabilities		288		288
	Total long-term liabilities		590		590
	Total liabilities not held for sale	$	1,632	$	1,602

Note_10_Operating_Segments_Tab

Note 10 - Operating Segments (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]		Treatment			Services			Segments			Corporate			-1	Consolidated
								Total			And Other				Total
	Revenue from external customers	$	9,749		$	3,851		$	13,600		$	—			$	13,600
	Intercompany revenues		2			8			10			—				—
	Gross profit		1,235			243			1,478			—				1,478
	Interest income		—			—			—			8				8
	Interest expense		(22	)		—			(22	)		(104	)			(126	)
	Interest expense-financing fees		—			—			—			(58	)			(58	)
	Depreciation and amortization		764			190			954			12				966
	Segment profit (loss), net of taxes		185			(303	)		(118	)		(1,896	)			(2,014	)
	Expenditures for segment assets		104			16			120			1				121
		Treatment			Services			Segments			Corporate			-1	Consolidated
								Total			And Other				Total
	Revenue from external customers	$	7,673		$	2,871		$	10,544		$	—			$	10,544
	Intercompany revenues		1			11			12			—				—
	Gross profit (negative gross profit)		111			(17	)		94			—				94
	Interest income		—			—			—			7				7
	Interest expense		(10	)		—			(10	)		(143	)			(153	)
	Interest expense-financing fees		—			—			—			(45	)			(45	)
	Depreciation and amortization		949			249			1,198			13				1,211
	Segment loss, net of taxes		(1,174	)		(1,048	)		(2,222	)		(1,481	)			(3,703	)
	Expenditures for segment assets		211			2			213			—				213

Note_3_Intangible_Assets_Detai

Note 3 - Intangible Assets (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 3 - Intangible Assets (Details) [Line Items]
Amortization of Intangible Assets	$127,000	$176,000
PCB Permit [Member]
Note 3 - Intangible Assets (Details) [Line Items]
Number Of Definte-Lived Permits	1

Note_3_Intangible_Assets_Detai1

Note 3 - Intangible Assets (Details) - Other Intangible Assets (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$4,809	$4,802
Accumulated Amortization	-2,267	-2,140
Net Carrying Amount	2,542	2,662
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives (Years)	8 years
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives (Years)	18 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	512	512
Accumulated Amortization	-177	-168
Net Carrying Amount	335	344
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives (Years)	3 years
Gross Carrying Amount	382	375
Accumulated Amortization	-339	-319
Net Carrying Amount	43	56
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives (Years)	12 years
Gross Carrying Amount	3,370	3,370
Accumulated Amortization	-1,419	-1,335
Net Carrying Amount	1,951	2,035
Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives (Years)	10 years
Gross Carrying Amount	545	545
Accumulated Amortization	-332	-318
Net Carrying Amount	$213	$227

Note_3_Intangible_Assets_Detai2

Note 3 - Intangible Assets (Details) - Summary of Expected Amortization Over the Next Five Years (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Summary of Expected Amortization Over the Next Five Years [Abstract]
2015 (remaining)	$376
2016	425
2017	391
2018	361
2019	280
	$1,833

Note_4_Capital_Stock_Stock_Pla2

Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) (USD $)	3 Months Ended				0 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Jul. 25, 2011	Dec. 31, 2014	Dec. 31, 2013
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0		0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	222,766	[1]	340,800	[1]		239,023	362,800
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	213,966		340,800
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)	$7.89	[1]	$9.62	[1]		$7.81	$9.53
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years	[1]	2 years 255 days	[1]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in Dollars per share)	$2.79		$2.79
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in Dollars per share)	$14.75		$14.75
Reduction in Stock Based Compensation Expense (in Dollars)			$54,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	$0		$0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	112,000
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Remaining Fiscal Year (in Dollars)	40,000
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized, Next Twelve Months (in Dollars)	53,000
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized In Year Two (in Dollars)	$19,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	1,257		0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)	$2.79		$0
Employee Stock Option [Member] | Contractual Term with One-third Yearly Vesting [Member] | Chief Operating Officer [Member] | The 2010 Stock Option Plan [Member]
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Share Based Compensation Maximum Contractual Term					6 years
Employee Stock Option [Member] | The 2010 Stock Option Plan [Member]
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	55,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)	$5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 109 days
Director Stock Options [Member] | The 2003 Outside Directors Stock Plan [Member]
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	167,766
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	167,766
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)	$8.84
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	4 years 328 days
Chief Operating Officer [Member] | The 2010 Stock Option Plan [Member]
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					60,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)					7.85
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					3 years
The 2003 Outside Directors Stock Plan [Member]
Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross	16,075
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	1,257
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures	1,257
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)	$2.79
[1]	Options with exercise prices ranging from $2.79 to $14.75

Note_4_Capital_Stock_Stock_Pla3

Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) - Company Stock Plan (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Company Stock Plan [Abstract]
Options outstanding, share	239,023		362,800
Options outstanding, weighted average exercise price	$7.81		$9.53
Granted, Shares	0		0
Granted, Weighted Average Exercise Price	$0		$0
Exercised, shares	-1,257		0
Exercised, weighted average exercise price	$2.79		$0
Exercised, aggregate intrinsic value	$2,043		$0
Forfeited/expired, shares	-15,000		-22,000
Forfeited/expired, weighted average exercise price	$7.10		$8.17
Options outstanding end of period, shares	222,766	[1]	340,800	[1]
Options outstanding end of period, Weighted Average Exercise Price	$7.89	[1]	$9.62	[1]
Options outstanding end of period, Weighted Average Remaining Contractual Term	5 years	[1]	2 years 255 days	[1]
Options outstanding end of period, Aggregate Intrinsic Value	22,616	[1]	47,790	[1]
Exercisable, shares	167,766	[1]	334,800	[1]
Exercisable, weighted average exercise price	$8.84	[1]	$9.73	[1]
Exercisable, weighted average remaining contractual term	4 years 328 days	[1]	2 years 219 days	[1]
Exercisable, aggregate intrinsic value	22,616	[1]	37,710	[1]
Vested/expect to be vested, shares	213,966		340,800
Vested/expect to be vested, weighted average exercise price	$8.01		$9.62
Vested/expect to be vested, weighted average remaining contractual term	5 years		2 years 255 days
Vested/expect to be vested, aggregate intrinsic value	$22,616		$47,790
[1]	Options with exercise prices ranging from $2.79 to $14.75

Note_4_Capital_Stock_Stock_Pla4

Note 4 - Capital Stock, Stock Plans and Stock Based Compensation (Details) - Stock-based Compensation Recognized (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock Options	$33,000	($18,000)
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock Options	13,000	-39,000
Director Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock Options	$20,000	$21,000

Note_5_Loss_Per_Share_Details

Note 5 - Loss Per Share (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	185,800	316,800

Note_6_Long_Term_Debt_Details

Note 6 - Long Term Debt (Details) (USD $)	0 Months Ended	12 Months Ended	0 Months Ended		3 Months Ended	0 Months Ended	1 Months Ended
	Aug. 02, 2013	Dec. 31, 2014	Oct. 31, 2011	Jul. 28, 2014	Mar. 31, 2015	Feb. 12, 2013	Jan. 31, 2015
Note 6 - Long Term Debt (Details) [Line Items]
Long-term Debt		11,372,000			$11,977,000
Share Price (in Dollars per share)	$2.23
Lenders [Member] | Promissory Note dated August 2, 2013 [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Proceeds from Issuance of Long-term Debt	3,000,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)	35,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$2.23
Warrants Exercisable Term	6 months
Warrants Not Settleable in Cash, Fair Value Disclosure	59,000
Stock Issued During Period, Shares, Other (in Shares)	90,000
Number of Shares Received by each Lender (in Shares)	45,000
Stock Issued During Period, Value, Other	200,000
Maximum Number of Payoffs of Shares in Terms of Outstanding Equity		20.00%
Amended Loan Agreement [Member] | Revolving Credit Facility [Member] | PNC Bank [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			12,000,000
Amendment 4 [Member] | Term Loan [Member] | PNC Bank [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Long-term Debt			16,000,000
Debt Instrument, Periodic Payment, Principal			190,000
Debt Instrument, Term			7 years
Amendment 6 [Member] | PFSG [Member] | PNC Bank [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility Reduction				1,500,000
Proceeds from Insurance Settlement, Investing Activities				3,850,000
Amendment 6 [Member] | PNC Bank [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility Reduction					1,500,000
Promissory Notes and Installment Agreements [Member] | TNC [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount						230,000
Prinicipal Balance of Promissory Note Cancelled as Part of Legal Settlement Arising from Business Acquisition						1,460,000
Repayments of Unsecured Debt							10,000
Promissory Note dated August 2, 2013 [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount		137,000			115,000
Revolving Credit Facility [Member] | PNC Bank [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility, Current Borrowing Capacity					$3,023,000

Note_6_Long_Term_Debt_Details_

Note 6 - Long Term Debt (Details) - Long-term Debt Instruments (USD $)	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Long-term debt	$11,977,000	$11,372,000
Less current portion of long-term debt	3,723,000	3,733,000
	8,254,000	7,639,000
Capital lease (interest at rate of 6.0%)	41,000	47,000
Revolving Credit [Member]
Debt Instrument [Line Items]
Long-term debt	1,545,000
Term Loan [Member]
Debt Instrument [Line Items]
Long-term debt	8,381,000	8,952,000
Promissory Note dated February 12, 2013 ("New Note") [Member]
Debt Instrument [Line Items]
Long-term debt		10,000
Promissory Note dated August 2, 2013 [Member]
Debt Instrument [Line Items]
Long-term debt	$2,010,000	$2,363,000

Note_6_Long_Term_Debt_Details_1

Note 6 - Long Term Debt (Details) - Long-term Debt Instruments (Parentheticals) (USD $)	3 Months Ended
	Mar. 31, 2015
Debt Instrument [Line Items]
Effective interest rate	6.00%
Revolving Credit [Member] | Prime Rate [Member]
Debt Instrument [Line Items]
Reference rate	3.25%
Revolving Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Revolving Credit [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	3.00%
Effective interest rate	3.80%
Term Loan [Member] | Prime Rate [Member]
Debt Instrument [Line Items]
Periodic payment, principal (in Dollars)	190,000
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	2.50%
Term Loan [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	3.50%
Effective interest rate	3.70%
Promissory Note dated February 12, 2013 ("New Note") [Member]
Debt Instrument [Line Items]
Effective interest rate	6.00%
Periodic payment, principal (in Dollars)	10,000
Promissory Note dated August 2, 2013 [Member]
Debt Instrument [Line Items]
Effective interest rate	2.99%
Periodic payment, principal (in Dollars)	125,000

Note_7_PermaFix_Medical_SA_Det

Note 7 - Perma-Fix Medical S.A. (Details) (USD $)	3 Months Ended	0 Months Ended	8 Months Ended
	Mar. 31, 2015	Apr. 04, 2014	Mar. 31, 2015	Aug. 31, 2014
Note 7 - Perma-Fix Medical S.A. (Details) [Line Items]
Cash From Capital Transaction, to Be Received	$592,000
PF Medical S.A. [Member]
Note 7 - Perma-Fix Medical S.A. (Details) [Line Items]
Capital Investment in Publicly Traded Shell Company, Percentage Acquired		64.00%
Series E Common Stock [Member] | Private Placement [Member] | PF Medical S.A. [Member]
Note 7 - Perma-Fix Medical S.A. (Details) [Line Items]
Common Stock, Value, Subscriptions				2,357,000
Common Stock, Shares Subscribed but Unissued (in Shares)				250,000
Series E Common Stock [Member] | PF Medical S.A. [Member]
Note 7 - Perma-Fix Medical S.A. (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)			250,000
Payments of Stock Issuance Costs			242,000
PF Medical S.A. [Member]
Note 7 - Perma-Fix Medical S.A. (Details) [Line Items]
Cash Received From Capital Transaction	$67,000		$1,545,000
Series E Common Stock SharesTo Be Issued (in Shares)	68,181

Note_8_Commitments_and_Conting1

Note 8 - Commitments and Contingencies (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Note 8 - Commitments and Contingencies (Details) [Line Items]
Bonds and Letters of Credit Outstanding, Amount	$1,773,000
PFNWR Facility [Member] | Minimum [Member] | American International Group, Inc [Member]
Note 8 - Commitments and Contingencies (Details) [Line Items]
Renewal Fee for Additional Year Under Second Insurance Policy		41,000
PFNWR Facility [Member] | Maximum [Member] | American International Group, Inc [Member]
Note 8 - Commitments and Contingencies (Details) [Line Items]
Renewal Fee for Additional Year Under Second Insurance Policy		46,000
PFNWR Facility [Member] | American International Group, Inc [Member]
Note 8 - Commitments and Contingencies (Details) [Line Items]
Interest Income, Other	1,000
Financial Assurance Coverage Amount Under Second Insurance Policy	7,800,000
Annual Growth Rate of Financial Assurance Coverage Amount Under Second Insurance Policy	1.50%
Maximum Financial Assurance Coverage Amount Under Second Insurance Policy	8,200,000
Sinking Fund Related to Second Insurance Policy	5,906,000
Interest Earned on Sinking Fund Under Second Insurance Policy	206,000
Period of Finite Second Insurance Policy	4 years
American International Group, Inc [Member]
Note 8 - Commitments and Contingencies (Details) [Line Items]
Period of Finite Risk Insurance Policy	25 years
Maximum AllowableCoverageOfInsurancePolicy	39,000,000
Financial Assurance Coverage Amount Under Insurance Policy	38,454,000
Sinking Fund Related to Insurance Policy	15,435,000
Interest Earned on Sinking Fund	963,000
Interest Income, Other	$6,000
Insurers Obligation to Entity on Termination of Contract	100.00%

Note_9_Discontinued_Operations2

Note 9 - Discontinued Operations (Details) (USD $)	3 Months Ended	0 Months Ended	12 Months Ended
	Mar. 31, 2015	Aug. 14, 2013	Dec. 31, 2014
Note 9 - Discontinued Operations (Details) [Line Items]
Number of Previously Shut Down Locations	2
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$47,962,000		$47,123,000
PFSG Facility Fire Damage [Member] | PFSG [Member]
Note 9 - Discontinued Operations (Details) [Line Items]
Maximum Deductible Amount in Insurance for General Liability		300,000
Assets Held-for-sale [Member]
Note 9 - Discontinued Operations (Details) [Line Items]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	0		0
Not Held For Sale [Member]
Note 9 - Discontinued Operations (Details) [Line Items]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	10,000		10,000
PFSG [Member]
Note 9 - Discontinued Operations (Details) [Line Items]
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax	-223,000		-266,000
Discontinued Operation, Tax Effect of Other Income (Loss) from Disposition of Discontinued Operation	0		0
Disposal Group, Including Discontinued Operation, Revenue	$0		$0

Note_9_Discontinued_Operations3

Note 9 - Discontinued Operations (Details) - Discontinued Operations (USD $)	Mar. 31, 2015		Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets
Other assets	$5		$6
Total current assets	5		6
Long-term assets
Property, plant and equipment, net (1)	644	[1]	644	[1]
Total long-term assets	644		644
Total assets held for sale	649		650
Current liabilities
Accounts payable	883		932
Accrued expenses and other liabilities	202		193
Total current liabilities	1,085		1,125
Total liabilities held for sale	1,085		1,125
Current assets
Other assets	13		14
Total current assets	13		14
Long-term assets
Property, plant and equipment, net (1)	37	[2]	37	[2]
Total long-term assets	37		37
Total assets not held for sale	50		51
Current liabilities
Accounts payable	33		15
Accrued expenses and other liabilities	281		269
Environmental liabilities	728		728
Total current liabilities	1,042		1,012
Long-term liabilities
Closure liabilities	302		302
Environmental liabilities	288		288
Total long-term liabilities	590		590
Total liabilities not held for sale	$1,632		$1,602
[1]	net of accumulated depreciation of $0 for each period presented.
[2]	net of accumulated depreciation of $10,000 for each period presented.

Note_10_Operating_Segments_Det

Note 10 - Operating Segments (Details)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Number of Reportable Segments	2

Note_10_Operating_Segments_Det1

Note 10 - Operating Segments (Details) - Segment Financial Information (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Segment Reporting Information [Line Items]
Revenue from external customers	$13,600		$10,544
Gross profit (loss)	1,478		94
Interest income	8		7
Interest expense	-126		-153
Interest expense-financing fees	-58		-45
Depreciation and amortization	966		1,211
Segment profit (loss), net of taxes	-2,014		-3,703
Expenditures for segment assets	121		213
Treatment [Member]
Segment Reporting Information [Line Items]
Revenue from external customers	9,749		7,673
Intercompany revenues	2		1
Gross profit (loss)	1,235		111
Interest expense	-22		-10
Depreciation and amortization	764		949
Segment profit (loss), net of taxes	185		-1,174
Expenditures for segment assets	104		211
Services [Member]
Segment Reporting Information [Line Items]
Revenue from external customers	3,851		2,871
Intercompany revenues	8		11
Gross profit (loss)	243		-17
Depreciation and amortization	190		249
Segment profit (loss), net of taxes	-303		-1,048
Expenditures for segment assets	16		2
Segments Total [Member]
Segment Reporting Information [Line Items]
Revenue from external customers	13,600		10,544
Intercompany revenues	10		12
Gross profit (loss)	1,478		94
Interest expense	-22		-10
Depreciation and amortization	954		1,198
Segment profit (loss), net of taxes	-118		-2,222
Expenditures for segment assets	120		213
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenue from external customers		[1]		[1]
Intercompany revenues		[1]		[1]
Gross profit (loss)		[1]		[1]
Interest income	8	[1]	7	[1]
Interest expense	-104	[1]	-143	[1]
Interest expense-financing fees	-58	[1]	-45	[1]
Depreciation and amortization	12	[1]	13	[1]
Segment profit (loss), net of taxes	-1,896	[1]	-1,481	[1]
Expenditures for segment assets	$1	[1]		[1]
[1]	Amounts reflect the activity for corporate headquarters (in both periods presented) and PF Medical S.A. (for quarter ended March 31, 2015 only), not included in the segment information.

Note_11_Income_Taxes_Details

Note 11 - Income Taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$36,000	$30,000
Effective Income Tax Rate Reconciliation, Percent	2.00%	0.08%

Note_12_Subsequent_Events_Deta

Note 12 - Subsequent Events (Details) (USD $)	1 Months Ended
	Apr. 30, 2015	Apr. 17, 2015	Jun. 30, 2015
Generator Project [Member] | Subsequent Event [Member] | Perma-Fix Medical, S.A. [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Grants Receivable	800,000
Generator Project [Member] | Subsequent Event [Member] | U.S. Company [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Number Of Additional Entities Associated With The Project	4
Generator Project [Member] | Subsequent Event [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Grant Budget Amount	3,700,000
Allocated Grant Subsidies	2,800,000
Project Funding, Period	4 years
Generator Project [Member] | Scenario, Forecast [Member] | Perma-Fix Medical, S.A. [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Grants Receivable			240,000
Subsequent Event [Member] | Minimum [Member] | Chief Executive Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		5.00%
Performance Compensation, Amount		13,556
Subsequent Event [Member] | Minimum [Member] | Chief Operating Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		5.00%
Performance Compensation, Amount		10,750
Subsequent Event [Member] | Minimum [Member] | Chief Financial Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		5.00%
Performance Compensation, Amount		10,712
Subsequent Event [Member] | Maximum [Member] | Chief Executive Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		100.00%
Performance Compensation, Amount		271,115
Subsequent Event [Member] | Maximum [Member] | Chief Operating Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		100.00%
Performance Compensation, Amount		215,000
Subsequent Event [Member] | Maximum [Member] | Chief Financial Officer [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compensation, Percent		100.00%
Performance Compensation, Amount		$214,240
Subsequent Event [Member] | Maximum [Member] | CEO, COO, and CFO [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Performance Compenstion, Prior Pre-tax Net Income Calculation, Percent		50.00%